Title X Grantees and Clinics Affected by the Trump Administration’s Funding Freeze
This data note looks at the Title X grantees and clinics affected by the Trump Administration’s recent funding freeze.
Read More
Report: Virtual GI Solutions Save Money, Improve Patient Symptoms
A report from the Peterson Health Technology Institute found that virtual gastrointestinal solutions can improve symptoms for patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease while lowering healthcare spending. The post Report: Virtual GI Solutions Save Money, Improve Patient Symptoms appeared first on MedCity News.
Carrum Health Expands SUD Treatment Program to Include Nearly All Substances
Carrum Health has expanded its value-based substance use program to include cannabis, sedatives and stimulants. The post Carrum Health Expands SUD Treatment Program to Include Nearly All Substances appeared first on MedCity News.
Maybe AI Doesn’t Read Blueprints
By KIM BELLARD Gosh, who knew that Jan 13 would be an AI day, with at least three major announcements about “blueprints” for its development going forward? Of course, these days every day is an AI day; trying to take in all AI-related news can be overwhelming. But before some other AI news drowns them…
Trump quiere que Harris pague un precio político por ofrecer salud a inmigrantes sin papeles
María Sánchez emigró al área de Chicago desde México hace unos 30 años. Ahora, a sus 87, sigue viviendo en Estados Unidos sin papeles. Como muchos inmigrantes de larga data, ha trabajado —y pagado impuestos, incluyendo para Medicare— durante todo ese tiempo. Pero Sánchez nunca tuvo seguro médico, y cuando cumplió 65, no pudo inscribirse…
The new OMB Social Welfare Function
Recently, the Office of Management and Budget has released new procedures to assess government regulation (Circular A-4) and economic policies (Circular A-94). What is unique about this guidance is that it weights benefits and costs of new regulations and policies based on the income of the individuals impacted. The goal is to help reduce inequality….
Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins
This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during the first ACA open enrollment period since its approval. Despite the drug widely being considered a major advance, early evidence suggests that insurance coverage and benefit design decisions may create barriers to access.
Explaining Cost-Sharing Reductions and Silver Loading in ACA Marketplaces
The House of Representatives recently passed a budget reconciliation bill that would appropriate funding for cost-sharing reductions that insurers are required to provide to low-income enrollees in the Affordable Care Act marketplace. This brief explains what these cost-sharing reductions are, how they relate to federal spending, and what effect appropriating funding might have on premiums…
GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in $2.2B Deal
Rapt Therapeutics brings to GSK ozureprubart, a long-acting antibody that inhibits the validated immunology target immunoglobulin E (IgE). If GSK is able to bring this drug to the market, it would complete with the blockbuster Genentech and Novartis allergy drug Xolair. The post GSK Grows in Immunology, Buying Rapt Therapeutics and Food Allergy Drug in…
The Implications of Federal SNAP Spending Cuts on Individuals with Medicaid, Medicare and Other Health Coverage
Proposed changes in eligibility rules in both SNAP and Medicaid may jeopardize some people’s access to both adequate food and health care if various provisions of the bill take effect, in part because there is a significant overlap in eligibility requirements for Medicaid and SNAP across states. Four in 10 (40%) Medicaid enrollees receive SNAP…